Different jobs, different rules
Cosmetic peptides are formulated for topical use in skincare and are regulated as cosmetics or specialty ingredients depending on claims and region. Research peptides sold as lyophilized vials for laboratory experiments occupy another market entirely—even when some sequences overlap in popular discussion.
Exposure route changes everything
Topical application faces the skin barrier; systemic injection does not. Concentration, impurity tolerances, sterility, and legal frameworks diverge. Treating a cosmetic ingredient like an injectable research chemical is a category error.
Shared chemistry themes
Both worlds use peptide modification tricks—palmitoylation for skin penetration (Matrixyl), copper binding (GHK-Cu), short signal motifs (SNAP-8). Learning the chemistry transfers; the use case does not.
Sources and what they cover
These primary studies, official records and standards cover the topics linked below. The scope notes distinguish laboratory findings, human trials and regulatory records. This is a selected bibliography, not a systematic review or verification of every sentence; absence of a study here does not prove that no study exists.
- Maquart et al. (1988) — GHK-Cu and collagen synthesis in fibroblast cultures
Cell-culture collagen endpoint, not a human injectable skin or hair trial.
Relevant sections: Exposure route changes everything · Shared chemistry themes
- Health Canada (2026) — unauthorized injectable peptides bought online
Canadian safety and authorization notice for the products described. It does not establish approval status in every country.
Relevant sections: Different jobs, different rules · Exposure route changes everything
FAQ
Is GHK-Cu a research peptide or cosmetic?+
It appears in both conversations. Copper tripeptide is common in skincare science and also discussed in research contexts. Product form and claims determine the regulatory bucket.